FGF23, which is low in HHRH, but elevated in XLH and TIO, was shown to induce left ventricular hypertrophy via activation of the calcineurin-NFAT signaling pathway32, but whether FGF23 impacts skeletal muscle function is unclear33. Here, FGF23 is linked to X-linked hypophosphatemia.